Levamisole (Ergamisol)

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

This agent is not commercially available in the United States and is included for historic purposes only.

Diseases for which it was used

History of changes in FDA indication

1990-06-18: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. (Based on Laurie et al. 1989 & SWOG S8591)

History of changes in EMA indication

1966-06-14: EURD

Also known as

Brand name: Ergamisol

Retrieved from "https://hemonc.org/w/index.php?title=Levamisole_(Ergamisol)&oldid=74811"